Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 15, 2019
The article explores the transformative potential of combining facial recognition with AI to identify rare genetic disorders. Highlighting advancements in technology, it details how FDNA AI-driven facial analysis can detect subtle facial features associated with specific genetic conditions, thus aiding in early diagnosis and intervention. This innovative approach promises to enhance the accuracy and speed of identifying rare genetic disorders, providing a crucial tool for healthcare professionals. By leveraging these advanced techniques, Face2Gene has significant impact on medical diagnostics and patient care, demonstrating how technology is revolutionizing the detection and management of rare genetic conditions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…